Ulobetasol
Clinical data | |
---|---|
Trade names | Ultravate |
Other names | (6S,8S,9S,10S,11S,13S,14S,16S,17R)-17-(2-Chloroacetyl)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one, halobetasol (USAN US) |
AHFS/Drugs.com | Professional Drug Facts |
MedlinePlus | a601060 |
ATC code |
|
Identifiers | |
| |
JSmol) | |
| |
| |
(what is this?) (verify) |
Ulobetasol (
INN) or halobetasol (USAN) is a corticosteroid used to treat psoriasis.[1][2] It is a class I corticosteroid under the US classification and a group III corticosteroid under international classification, the most potent group of such drugs.[3][4]
Ulobetasol propionate is usually supplied as a 0.05% topical cream.[1] Ulobetasol is the strongest topical steroid available.[citation needed] It is also sold with tazarotene with 0.01% halobetasol and 0.045% tazarotene as a lotion branded as Duobrii (Bausch Health).
It is available as a
generic medication.[5]
References
External links
- "Halobetasol". Drug Information Portal. U.S. National Library of Medicine.
- "Halobetasol propionate". Drug Information Portal. U.S. National Library of Medicine.
- halobetasol at the U.S. National Library of Medicine Medical Subject Headings (MeSH)